Gestational Diabetes in Uganda and India Improving Screening and Self-management (GUIDES)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03937050|
Recruitment Status : Not yet recruiting
First Posted : May 3, 2019
Last Update Posted : May 16, 2019
This trial will evaluate a package of three interconnected educational/behavioural interventions aimed at: a) improving knowledge and skills of GDM guidelines and skills of health providers; b) raising awareness of importance of GDM screening among pregnant women and their families; and c) improving confidence and skills in self-management among those diagnosed with GDM. The interventions will be delivered through the medium of film as they are low-cost and scalable, and are particularly suitable for people who are not very literate, making them ideal for low- and middle-income countries (LMICs).
The research will be carried out in Uganda (Entebbe) and India (Bengaluru). A careful contextual analysis will precede the development of a culturally-tailored film-based intervention for each setting, which will be iteratively refined using qualitative research methods till it is fit for purpose. The effectiveness of the intervention will be evaluated in independent cluster randomised trials, involving ~10,000 pregnant women across 30 maternity units at each site. The films will be made available in the intervention arm facilities: for viewing by doctors and nurses at their meetings, for continual screening in waiting areas of antenatal clinics, and during group education sessions (and personal mobile use) for GDM patients. Where video/projection facilities are unavailable, small low-cost projectors will be made available. Control arms will follow usual care practices.
The principal research question is whether a low-cost educational/behavioural intervention delivered through a package of culturally-tailored films can provide scalable improvements in timely detection and management of GDM. This will be evaluated through assessing three endpoints: a) detection of GDM at 32 weeks of; b) glycaemic control (fasting glucose) in women with GDM at ~34 weeks of pregnancy; and c) adverse perinatal outcomes associated with GDM. Interviews will be conducted with women and health providers to help understand how and why the intervention may be (or may not be) successful. The ultimate aim of the project is to contribute to scientific evidence underpinning the use of films in cost-effectively scaling up behavioural interventions in low literacy settings.
|Condition or disease||Intervention/treatment||Phase|
|Gestational Diabetes||Behavioral: Intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20000 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Gestational Diabetes in Uganda and India: Design and Evaluation of Educational Films for Improving Screening and Self-management|
|Estimated Study Start Date :||September 1, 2019|
|Estimated Primary Completion Date :||March 1, 2021|
|Estimated Study Completion Date :||July 1, 2021|
A package of three interconnected educational/behavioural film-based interventions will developed for delivery at the cluster (clinic) level. The aim of the three components will be as follows: a) improving knowledge of GDM guidelines and skills among health providers involved in GDM management, b) raising awareness of GDM and the importance of screening among pregnant women and their family members, and c) improving confidence and skills in self-management of GDM among women diagnosed.
Three film-based components:
No Intervention: Control
Usual care practices.
- GDM diagnosis [ Time Frame: 32 weeks of pregnancy ]Proportion of women with a diagnosis of GDM. Self-reported via telephone contact.
- Mean fasting blood sugar (women with GDM) [ Time Frame: 34 weeks of pregnancy ]Mean fasting blood sugar in women diagnosed with GDM. Measured at clinic visit.
- Adverse perinatal outcomes (composite measure) [ Time Frame: 6 weeks post-partum ]Proportion of women with adverse perinatal outcomes related to GDM (composite of Caesarean section delivery, perinatal mortality, and infant hospitalization within 6 weeks of delivery). Self-reported via telephone contact post delivery.
- HbA1c (women with GDM) [ Time Frame: 34 weeks. ]Average blood sugar level in women diagnosed with GDM. Measured at clinic visit.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03937050
|Contact: Laura Oakley||00 44 207 firstname.lastname@example.org|
|Principal Investigator:||Sanjay Kinra||London School of Hygiene and Tropical Medicine|